Discussion: Anaplastic large cell lymphoma and breast implants: A systematic review

Plastic and Reconstructive Surgery

Volumn 127, Issue 6, 2011, Pages 2151-2153

  Kenkel, Jeffrey M ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST ENDOPROSTHESIS; BREAST TUMOR; FEMALE; HUMAN; LARGE CELL LYMPHOMA; NOTE;

BREAST IMPLANTS; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHOMA, LARGE-CELL, ANAPLASTIC;

EID: 79958723467     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e318219c741     Document Type: Note

References (4)

1. Eaves FE, Rohrich RJ. So you want to be an evidence-based plastic surgeon? A lifelong journey. Aesth Surg J. 2011;31: 137-142.
2. U.S. Food and Drug Administration, U.S. Department of Health andHumanServices.FDAmedical device safety communication: Reports of anaplastic large cell lymphoma (ALCL) in women with breast implants. Silver Spring, Md: U.S. Food and Drug Administration. January 26, 2011. Available at: http://www.fda. gov/MedicalDevices/Safety/AlertsandNotices/ucm240000. htm. Accessed March 3, 2011.
3. Swanson J, Schmitz D, Chung K. How to practice evidencebased medicine. Plast Reconstr Surg. 2010;126:286-294.
4. American Society of Plastic Surgeons. ASPS collaborates with FDA to establish breast implant registry. Arlington Heights, Ill: American Society of Plastic Surgeons. January 26, 2011. Available at: http://www.plasticsurgery.org/ Media/Press-Releases/ASPS- Collaborates-with-FDA-to-Establish-Breast-Implant- Registry. html. Accessed March 3, 2011.